535 related articles for article (PubMed ID: 16814911)
41. Dependence of asbestos- and mineral dust-induced transformation of mammalian cells in culture on fiber dimension.
Hesterberg TW; Barrett JC
Cancer Res; 1984 May; 44(5):2170-80. PubMed ID: 6324999
[TBL] [Abstract][Full Text] [Related]
42. Evaluation of the deposition, translocation and pathological response of brake dust with and without added chrysotile in comparison to crocidolite asbestos following short-term inhalation: interim results.
Bernstein DM; Rogers R; Sepulveda R; Kunzendorf P; Bellmann B; Ernst H; Phillips JI
Toxicol Appl Pharmacol; 2014 Apr; 276(1):28-46. PubMed ID: 24480151
[TBL] [Abstract][Full Text] [Related]
43. Incorporation of bromodeoxyuridine (BrdU) in the bronchiolar-alveolar regions of the lungs following two inhalation exposures to chrysotile asbestos in strain A/J mice.
Dixon D; Bowser AD; Badgett A; Haseman JK; Brody AR
J Environ Pathol Toxicol Oncol; 1995; 14(3-4):205-13. PubMed ID: 9003699
[TBL] [Abstract][Full Text] [Related]
44. Asbestos mineralogic analysis as indicator of carcinogenic risk.
Frank AL
Med Lav; 1995; 86(5):490-5. PubMed ID: 8684300
[TBL] [Abstract][Full Text] [Related]
45. [Do advers health effects of chrysotile and amphibole asbestos differ?].
Baur X; Schneider J; Woitowitz HJ; Velasco Garrido M
Pneumologie; 2012 Aug; 66(8):497-506. PubMed ID: 22875734
[TBL] [Abstract][Full Text] [Related]
46. A study of airborne chrysotile concentrations associated with handling, unpacking, and repacking boxes of automobile clutch discs.
Jiang GC; Madl AK; Ingmundson KJ; Murbach DM; Fehling KA; Paustenbach DJ; Finley BL
Regul Toxicol Pharmacol; 2008 Jun; 51(1):87-97. PubMed ID: 18440685
[TBL] [Abstract][Full Text] [Related]
47. An epidemiological study of the role of chrysotile asbestos fibre dimensions in determining respiratory disease risk in exposed workers.
Stayner L; Kuempel E; Gilbert S; Hein M; Dement J
Occup Environ Med; 2008 Sep; 65(9):613-9. PubMed ID: 18096653
[TBL] [Abstract][Full Text] [Related]
48. Lung cancer in chrysotile asbestos workers: analyses based on the two-stage clonal expansion model.
Richardson DB
Cancer Causes Control; 2009 Aug; 20(6):917-23. PubMed ID: 19184474
[TBL] [Abstract][Full Text] [Related]
49. An overview of the risk of lung cancer in relation to exposure to asbestos and of taconite miners.
Berry G; Gibbs GW
Regul Toxicol Pharmacol; 2008 Oct; 52(1 Suppl):S218-22. PubMed ID: 17998152
[TBL] [Abstract][Full Text] [Related]
50. Mesothelioma and asbestos.
Gibbs GW; Berry G
Regul Toxicol Pharmacol; 2008 Oct; 52(1 Suppl):S223-31. PubMed ID: 18022298
[TBL] [Abstract][Full Text] [Related]
51. A review of carcinogenicity studies of asbestos and non-asbestos tremolite and other amphiboles.
Addison J; McConnell EE
Regul Toxicol Pharmacol; 2008 Oct; 52(1 Suppl):S187-99. PubMed ID: 18006199
[TBL] [Abstract][Full Text] [Related]
52. Mortality from occupational exposure to relatively pure chrysotile: a 39-year study.
Sichletidis L; Chloros D; Spyratos D; Haidich AB; Fourkiotou I; Kakoura M; Patakas D
Respiration; 2009; 78(1):63-8. PubMed ID: 18843176
[TBL] [Abstract][Full Text] [Related]
53. Adverse health effects of asbestos: solving mysteries regarding asbestos carcinogenicity based on follow-up survey of a Chinese factory.
Yano E
Environ Health Prev Med; 2018 Aug; 23(1):35. PubMed ID: 30089452
[TBL] [Abstract][Full Text] [Related]
54. Lung proliferative and clearance responses to inhaled para-aramid RFP in exposed hamsters and rats: comparisons with chrysotile asbestos fibers.
Warheit DB; Snajdr SI; Hartsky MA; Frame SR
Environ Health Perspect; 1997 Sep; 105 Suppl 5(Suppl 5):1219-22. PubMed ID: 9400727
[TBL] [Abstract][Full Text] [Related]
55. Evaluation of the dose-response and fate in the lung and pleura of chrysotile-containing brake dust compared to chrysotile or crocidolite asbestos in a 28-day quantitative inhalation toxicology study.
Bernstein DM; Toth B; Rogers RA; Sepulveda R; Kunzendorf P; Phillips JI; Ernst H
Toxicol Appl Pharmacol; 2018 Jul; 351():74-92. PubMed ID: 29705295
[TBL] [Abstract][Full Text] [Related]
56. The biopersistence of Canadian chrysotile asbestos following inhalation: final results through 1 year after cessation of exposure.
Bernstein D; Rogers R; Smith P
Inhal Toxicol; 2005 Jan; 17(1):1-14. PubMed ID: 15764479
[TBL] [Abstract][Full Text] [Related]
57. Mesothelioma in a worker who spun chrysotile asbestos at home during childhood.
Yano E; Wang ZM; Wang XR; Wang MZ; Takata A; Kohyama N; Suzuki Y
Am J Ind Med; 2009 Apr; 52(4):282-7. PubMed ID: 19143009
[TBL] [Abstract][Full Text] [Related]
58. Inhalation and injection studies in rats using dust samples from chrysotile asbestos prepared by a wet dispersion process.
Davis JM; Addison J; Bolton RE; Donaldson K; Jones AD
Br J Exp Pathol; 1986 Feb; 67(1):113-29. PubMed ID: 3004552
[TBL] [Abstract][Full Text] [Related]
59. [Evaluation of the mineral fibers content of pulmonary tissue in people engaged in extraction and concentration of chrysotile asbestos and in those living near enterprises].
Kovalevskiĭ EB; Tossavaĭnen A; Tuomi T; Vankhala E
Med Tr Prom Ekol; 2000; (11):13-9. PubMed ID: 11280277
[TBL] [Abstract][Full Text] [Related]
60. Measurement of elongate mineral particles: What we should measure and how do we do it?
Chatfield EJ
Toxicol Appl Pharmacol; 2018 Dec; 361():36-46. PubMed ID: 30134140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
